JP2021526552A5 - - Google Patents
Info
- Publication number
- JP2021526552A5 JP2021526552A5 JP2021515298A JP2021515298A JP2021526552A5 JP 2021526552 A5 JP2021526552 A5 JP 2021526552A5 JP 2021515298 A JP2021515298 A JP 2021515298A JP 2021515298 A JP2021515298 A JP 2021515298A JP 2021526552 A5 JP2021526552 A5 JP 2021526552A5
- Authority
- JP
- Japan
- Prior art keywords
- groups
- pharmaceutical composition
- composition according
- compound
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO20180714 | 2018-05-23 | ||
| NO20180714 | 2018-05-23 | ||
| PCT/IB2019/000655 WO2019224602A2 (en) | 2018-05-23 | 2019-05-22 | Structurally modified fatty acids for improving glycemic control and treating inflammatory bowel disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021526552A JP2021526552A (ja) | 2021-10-07 |
| JP2021526552A5 true JP2021526552A5 (https=) | 2022-05-30 |
| JP7508447B2 JP7508447B2 (ja) | 2024-07-01 |
Family
ID=67688797
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021515298A Active JP7508447B2 (ja) | 2018-05-23 | 2019-05-22 | 血糖制御を改善し、炎症性腸疾患を処置するための構造修飾脂肪酸 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20210290576A1 (https=) |
| EP (1) | EP3796901A2 (https=) |
| JP (1) | JP7508447B2 (https=) |
| KR (2) | KR20210015883A (https=) |
| CN (1) | CN112351775A (https=) |
| AU (1) | AU2019274203B2 (https=) |
| CA (1) | CA3101041A1 (https=) |
| WO (1) | WO2019224602A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102760537B1 (ko) | 2022-01-20 | 2025-02-03 | 한국과학기술연구원 | 삼원계 광활성층 조성물 및 이를 포함하는 유기태양전지 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009061208A1 (en) | 2007-11-09 | 2009-05-14 | Pronova Biopharma Norge As | Lipid compounds for use in cosmetic products, as food supplement or as a medicament |
| EP2147910A1 (en) * | 2008-07-15 | 2010-01-27 | Pronova BioPharma Norge AS | Novel lipid compounds |
| BRPI1015120B8 (pt) * | 2009-05-08 | 2022-02-15 | Basf As | Composto lipídico alfa-substituídos, derivados de ácidos graxos beta-oxo poli-insaturados, composição farmacêutica e lipídica e métodos para produzir composto lipídico e ácido 2-((5z,8z,11z,14z,17z)-icosa-5,8,11,14,17-pentaeniloxi)butanóico |
| EP2526084A1 (en) | 2010-01-20 | 2012-11-28 | Pronova BioPharma Norge AS | Salicylate fatty acid derivatives |
| CN102946875A (zh) * | 2010-05-05 | 2013-02-27 | 贝林格尔.英格海姆国际有限公司 | 组合疗法 |
| PL2961727T3 (pl) | 2013-02-28 | 2017-06-30 | Pronova Biopharma Norge As | Sposób wytwarzania kwasu 2-((5Z,8Z, 11Z,14Z,17Z)-ejkoza-5,8,11,14,17-pentaenyloksy)butanowego |
| KR20180010181A (ko) | 2015-04-01 | 2018-01-30 | 프로노바 바이오파마 너지 에이에스 | Apo c3 의 저하를 위한 티아 옥소 화합물의 용도 |
| ES2980790T3 (es) * | 2015-04-28 | 2024-10-03 | Basf As | Acidos grasos estructuralmente mejorados que contienen azufre para su uso en el tratamiento de la esteatohepatitis no alcohólica |
-
2019
- 2019-05-22 JP JP2021515298A patent/JP7508447B2/ja active Active
- 2019-05-22 KR KR1020207037063A patent/KR20210015883A/ko not_active Ceased
- 2019-05-22 AU AU2019274203A patent/AU2019274203B2/en active Active
- 2019-05-22 US US17/057,204 patent/US20210290576A1/en not_active Abandoned
- 2019-05-22 EP EP19756232.5A patent/EP3796901A2/en not_active Withdrawn
- 2019-05-22 CA CA3101041A patent/CA3101041A1/en active Pending
- 2019-05-22 CN CN201980034666.XA patent/CN112351775A/zh active Pending
- 2019-05-22 KR KR1020257032515A patent/KR20250150676A/ko active Pending
- 2019-05-22 WO PCT/IB2019/000655 patent/WO2019224602A2/en not_active Ceased
-
2025
- 2025-06-05 US US19/229,520 patent/US20260000632A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011528350A5 (https=) | ||
| US12129247B2 (en) | Administration regime for nitrocatechols | |
| JP2022512482A5 (https=) | ||
| JP2009530398A5 (https=) | ||
| JP2012097105A5 (https=) | ||
| JP2019048843A5 (https=) | ||
| MY153620A (en) | Novel sulphur containing lipids for use as food supplementor as medicament | |
| JP2016511753A5 (https=) | ||
| JP2004531543A5 (https=) | ||
| EA201171371A1 (ru) | Полиненасыщенные жирные кислоты для лечения заболеваний, связанных с сердечно-сосудистыми, метаболическими и воспалительными заболеваниями | |
| CN110105200A (zh) | 用于治疗纤维化的经取代的芳族化合物及相关方法 | |
| US20240166613A1 (en) | Proxisome proliferator activated receptor (ppar) compounds and methods of using the same | |
| JP2019524747A (ja) | 痛風または高尿酸血症に関連する症状を処置または予防するための化合物、組成物、および方法 | |
| JP6647278B2 (ja) | 化合物 | |
| JP2012502048A5 (https=) | ||
| JP4553166B2 (ja) | ニコチン酸エステルおよびそれを含む薬剤組成物 | |
| JP2015519322A5 (https=) | ||
| RU2017121460A (ru) | Производные пиридинкарбоксамида, способ их получения и их фармацевтическое применение | |
| JP5575651B2 (ja) | 新規のｄｈａ誘導体およびその医薬品としての用途 | |
| JP2016519106A5 (https=) | ||
| JP2015531376A5 (https=) | ||
| RU2013107759A (ru) | Производные оксадиазола и пиридазина, их получение и применение в терапии | |
| JP2021526552A5 (https=) | ||
| JP2024122966A (ja) | 芳香族化合物およびその医薬用途 | |
| JP2013536164A5 (https=) |